{"id":47018,"date":"2022-08-08T11:01:42","date_gmt":"2022-08-08T09:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/"},"modified":"2022-08-08T11:01:42","modified_gmt":"2022-08-08T09:01:42","slug":"pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/","title":{"rendered":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital"},"content":{"rendered":"
\n

LUGANO, Switzerland–(BUSINESS WIRE)–Pharma Tech Holding SA (\u201cPTH\u201d) announced today it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries.\n<\/p>\n

\nEstablished in 2019, PTH is a Swiss based holding company, which invests into innovative businesses with high technological value and scalability potential, mainly in Switzerland and Europe, with a focus on the health-tech, Agri-tech, and functional food.\n<\/p>\n

\nThis investment will allow PTH to mainly invest and support its portfolio company Blue Sky Swisse SA (\u201cBSS\u201d) a JV between PTH and listed company IGEA PHARMA NV (\u201cIgea\u201d), IGPH – ISIN NL0012768675. BSS focuses on the extraction of natural active principles from vegetable matrices, vegetable waste, and renewable sources to deliver B2B products under the form of CBD oil, Terpenes and Waxes. The factory located in Biasca, will be built to the state of art of extraction technology by super critical CO2 and will be energy self-sufficient through the use of solar photovoltaic panels and district heating. BSS will grant for highest CBD quality also due to a proprietary extraction process, starting from the farming performed under strict control and culminating with the immediate freezing of the flowers after harvest, with the target to also sell \u201call natural\u201d formulations to increase bioavailability thus enhancing the possible applications. Last, but not least, BSS will invest in the agricultural raw material chain and will create an aeroponic green house in Ticino, to deliver a high quality GMP Pharmaceutical CBD oil.\n<\/p>\n

\nLDA Capital agreed to commit an amount of up to CHF 30 million (the \u201cCapital Commitment\u201d) in cash within a maximum of three years. This Capital Commitment will be released based on drawdowns by PTH, that PTH has the right to exercise at its sole discretion.\n<\/p>\n

\n\u201cWe\u2019re thrilled with this partnership and are so glad that LDA Capital recognizes the value of PTH and its portfolio company, with the aim of creating one of the most innovative hub for health-tech, agri-tech and functional food,\u201d said Sabina Del Nigro, CEO at PTH.\n<\/p>\n

\nAbout Pharma Tech Holding:<\/b> Pharma Tech Holding SA (PTH) is a holding company based in Lugano, Switzerland, which invests into innovative businesses with high technological value and scalability potential, mainly in Switzerland and Europe, with a focus on the health-tech, Agri-tech, and functional food.\n<\/p>\n

\nAbout LDA Capital: <\/b>LDA Capital is a global alternative investment group with expertise in cross border transactions worldwide. Our team has dedicated their careers to international & cross border opportunities having collectively executed over 250 transactions in both the public and private middle markets across 43 countries with aggregate transaction values of over US$11 billion. For more information please visit: www.ldacap.com<\/a>; for inquiries please email: info@ldacap.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSabina Del Nigro
\n
Pharma Tech Holding SA
\n
info@pharmatechholding.com<\/a><\/p>\n

LDA Capital Ltd
\n
info@ldacap.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LUGANO, Switzerland–(BUSINESS WIRE)–Pharma Tech Holding SA (\u201cPTH\u201d) announced today it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47018","6":"format-standard","7":"category-industry"},"yoast_head":"\nPharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LUGANO, Switzerland–(BUSINESS WIRE)–Pharma Tech Holding SA (\u201cPTH\u201d) announced today it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-08T09:01:42+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital\",\"datePublished\":\"2022-08-08T09:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/\"},\"wordCount\":497,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/\",\"name\":\"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-08T09:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend","og_description":"LUGANO, Switzerland–(BUSINESS WIRE)–Pharma Tech Holding SA (\u201cPTH\u201d) announced today it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-08T09:01:42+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital","datePublished":"2022-08-08T09:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/"},"wordCount":497,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/","url":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/","name":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-08T09:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pharma-tech-holdings-sa-obtains-a-capital-commitment-agreement-of-chf-30-million-from-global-investor-lda-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47018"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47018\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}